CVS’ Finn Pathologists has invested in creating an innovative AI-assisted Ki-67 scoring system to help predict the behaviour of canine mast cell tumours, offering more accurate, efficient, and reliable prognostic evaluation. https://d8yy0r0qfxgnb.cloudfront.net/public/uploads/512fc0c75fafddc8f25a9bb6b8109c9b/companies/logos/512fc0c75fafddc8f25a9bb6b8109c9b/avatar/cvs_logo.png?1739265923 https://careers.cvsvets.com/ PageUp http://cyber.harvard.edu/rss/rss.html